Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2014 · 10-Q
Revenue$4.32B$4.32B+33.4% vs Q2 2013 Net income—
EPS Diluted$0.69$0.69−9.2% vs Q2 2013 Gross Profit$1,846,500,000+35.5% Operating Income$348,100,000−7.3% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$888,700,000+85.8% Free Cash Flowderived$813,200,000+97.0% Margins · derivedGross margin42.7%+0.7 pt vs Q2 2013
Operating margin8.1%−3.5 pt vs Q2 2013
ended Jun 28, 2014 · filed Aug 1, 2014 · 34 d after period end